A promising new drug holding the possibility of treatment with people suffering from a rare autoimmune disease such as thyroid eye disease (TED), Tepezza was well received on the market.
According to the manufacturer of the drug, the hearing-related side effects of Tepezza are non-typical and also reversible. This is what the manufacturer’s own clinical trials have shown before the drug was given its FDA approval in January 2020.
Only a year later, in January 2021, a small study conducted by a group of researchers from Stanford University revealed that not only that hearing-related adverse effects appear in a far greater percentage of Tepezza users than initially warned for, but many of these effects are also irreversible (permanent).
Among other possible side effects, Horizon Pharmaceuticals (the manufacturer of the Tepezza infusion treatment) warned that hearing loss or other otologic symptoms may occur in around 10% of Tepezza patients. Hearing-related adverse effects were estimated to be:
The first study to show that Horizon Pharmaceuticals failed to accurately warn Tepezza users and the doctors prescribing it about the hearing-related adverse effects involved with its usage was conducted by a small group of researchers at Stanford University and was presented at the annual meeting of the Endocrine Society, in January 2021.
The findings of this study revealed that hearing-related side effects of Tepezza infusion treatment are:
Having to deal with hearing loss, tinnitus, or other otologic symptoms as a result of the Tepezza infusion treatment while the treatment for thyroid eye disease lasts can already be a great ordeal. If these symptoms persist months after the treatment is stopped, the decrease in the quality of life can be significant and is something that nobody should ever experience.
If you or anybody among your loved ones has received several Tepezza infusion treatments and is suffering from hearing loss (partial or permanent), tinnitus (a ringing in the ear), autophony (an unusually loud perception of the patient’s own voice), or another hearing-related health injury, you might be entitled to compensation from the drug’s manufacturer.
Our team of experts at Atraxia Law has extensive experience of over 35 years in vetting defective drug claims, and we can help you:
Our process of determining eligibility is quick and effective.